Trial intelligence / Profile preview

NeSSy: Atypical vs Conventional Antipsychotics in Schizophrenia

NCT01164059Phase 4Completed

Sponsor
Universität Bremen
Start
Feb 2010
Primary completion
Aug 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of olanzapine, quetiapine, aripiprazole in schizophrenia, sponsored by Universität Bremen. Started Feb 2010; status: completed.

02

Drugs

olanzapinequetiapinearipiprazole
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT01164059.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01164059.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call